Skip to main content
Premium Trial:

Request an Annual Quote

NCI Awards Cyntellect $1.3M for Cell Cloning Technology Development

NEW YORK (GenomeWeb News) - Cyntellect said today it has received a Phase II Small Business Innovative Research grant from the National Cancer Institute worth $1.3 million to develop applications for its LEAP cell-imaging system.
 
LEAP (Laser-Enabled Analysis and Processing) is designed for high-throughput cell imaging and laser-based cell manipulation, the company said.
 
Cyntellect, based in San Diego, said it will use the award to develop applications that use LEAP for high-speed purification and cell cloning based on the secretion of native or recombinant proteins.
 
This capability should enable users to generate cell samples for biomarker and gene expression studies, develop cell lines for functional screening assays, improve efficiency in protein production, and other applications, Cyntellect said.

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.